Self-administered high-flow therapy for COPD and type 1 respiratory failure: benefit not proven

Oncotarget: Caspase-11 and AIM2 inflammasome involved in COPD and lung adenocarcinoma

Cell death discovery could lead to new treatment for COPD

Cell death discovery could lead to new treatment for COPD